Summary.-The importance of the contaminant OTS in the promoting activity of commercial saccharin on rat bladder neoplasia was investigated. OTS, OTS-free and OTS-contaminated saccharin were administered in the drinking water or diet for 2 years to groups of rats pretreated with an intravesical instillation of MNU; OTS alone and OTS-free saccharin were also given to groups of rats not pretreated with MNU.
DURING THE last 10 years, saccharin has been tested for carcinogenicity in rats, mice, hamsters and monkeys. Until recently (Arnold et al., 1977b) singlegeneration feeding studies have failed to demonstrate an unequivocal carcinogenic effect of saccharin in any of these species (Lessel, 197 1; Schmahl, 1973; Munro et al., 1.975; Kroes et al., 1977; Chowaniec & Hicks, 1979) . However, in 2-generation feeding studies, saccharin was found to induce bladder neoplasms in F1 male rats when fed at levels of 500 or 7. 50% in the diet (Taylor & Friedman, 1974; Tisdel et al., 1974; Arnold et al., 1977b) . Furthermore, the administration of saccharin either in the drinking water (2 g/kg/day) or diet (4 g/kg/day) to rats previously given a single sub-carcinogenic dose of N-methyl-N-nitrosourea (MNU) produced a high incidence of bladder tumours (Hicks et al., 1973a (Hicks et al., , 1975 (Hicks et al., , 1978 Hicks & Chowaniec, 1977; Hicks et al., 1978) . These findings suggested that saccharin could promote carcinogenesis initiated by MNU, and recent work by Cohen et al. (1979) confirmed a promoting effect of saccharin on bladder neoplasia after a threshold dose of N(4-(5-nitro-2-furyl)-2-thiazolyl) formamide (FANFT) .
A variety of impurities are present in commercial saccharin, the best known being ortho-toluene sulphonamide (OTS); this impurity has been detected at levels as high as 5000 pts/106 in saccharin manufactured by the Remsen-Fahlberg process, and has also been found, in much smaller amounts, in some batches of saccharin produced by the Maumee process. In the study by Hicks and her colleagues OTS was present at a concentration of 810 pts/106 (Hicks et al., 1973b) .
OTS is known to inhibit carbonic anhydrase (Kinzer, 1973) which could increase urinary pH, and favour the formation of urinary calculi. The possibility therefore arose that operation of such factors might have played a role in the carcinogenicity or promoting activity of saccharin.
The aim of the present experiments was therefore to examine the importance of OTS in carcinogenicity studies with saccharin, by comparing the incidence of neoplasia in MNU-pretreated bladders after long term administration of OTSfree saccharin, OTS-contaminated saccharin and OTS alone. OTS was also tested in rats not pretreated with MNU. The original experiments by Hicks and her co-workers used drinking water as the vehicle for saccharin administration, and the same vehicle was used in the main experiment of the current investigations (Exp. 1). However, some groups of rats developed signs of severe dehydration, so a second smaller experiment was set up in which compounds were administered in the diet (Exp. 2). Sixteen months after the start of Exp. 1, a supplementary study was initiated (Exp. 2). This consisted of 3 groups (H-J) each of 50 rats, housed 5 to a cage. The bladders of Group I rats were instilled with MNU as previously described. Eight days later, the groups were administered the appropriate chemicals in the diet. Group H received OTS-free saccharin at a desired level of 2 g/kg/day. To achieve this intake the concentration of saccharin in the diet was varied between 2 and 3-500 during the experiment. Groups I and J were fed OTS at a desired level of 70 mg/kg/day, providing a similar OTS intake to that in Groups E and G in Exp. 1. Administration of chemicals continued for 2 years.
MATERIALS AND METHODS

Materials
Measurements. Rats were observed daily for signs of ill health. Rats that became ill and whose condition did not improve were killed and subjected to a post mortem examination. Groups marked with asterisks differ significantly from their appropriate controls (Peto & Pike, 1973) . ***P < 0-001.
groups, only 2 and 7 rats respectively were still alive at 96 weeks. No significant differences in mortality were seen in Groups H-J in Exp. 2. Rats in Groups E and G weighed less than their relevant controls at the start of Exp. 1 and the differences had increased by 9 weeks (Table III) . By Week 25, the groups given saccharin in the drinking water (B and D) had also significantly smaller body-weight gains than the relevant controls, and the reduced body-weight gains in these 4 groups persisted throughout the experiment. In Exp. 2, no differences in body-weight were seen between rats receiving OTS with or without MNU, despite a slightly higher initial body weight in Group J. Rats from the saccharin-treated Group H tended to have slightly higher body weights than those in Groups I or J, but the differences were only statistically significant intermittently. Food and water consumptions
In Exp. 1, food consumption showed no consistent differences between the groups, with some groups having occasionally slightly higher or lower consumptions than corresponding controls. However, when the data were analysed on a cumulative basis between 4, 13, 41 and 92 weeks (Friedman, 1937) both the saccharintreated groups (B and D) and the highdose OTS group (E) showed reduced consumption (Table IV) .
In Exp. 2, occasional differences in food consumptions were also seen between the 3 groups, the cumulative food consumption being significantly higher in Group H.
Water consumption was decreased in groups receiving saccharin (B and D) or high-dose OTS (E and G) after 5 weeks of treatment in Exp. 1 and, by 13 weeks, the differences were statistically significant in all 4 groups. Consumption remained low in Groups E and G for the duration of the experiment, but in Group B, water intake had returned to control levels by 52 weeks, whereas Group D had raised consumption for the last year of the experiment. In Exp. 2, the saccharin treated Group H had a significantly higher cumulative water intake than Groups I and J.
The calculated daily intakes of saccharin and OTS in all groups are given in Tables I and V Groups B and D received rather less than this amount for the first 4 months of the study, and more during the last 12 months. Group H received slightly less than the desired intake throughout the study.
Urine studies and kidney weights
In Exps 1 and 2, some rats from all groups pretreated with MNU (A-E and I) had erythrocytes, acute inflammatory cells and cell debris in the urine when examined 2 weeks after MNU treatment. Intermittent haematuria was found in these groups throughout the experiments. Semi-quantitative tests for glucose, ketones, bile salts and albumin showed no marked differences between any groups. Crystalluria was observed in all groups, becoming more apparent after the first 6 months of treatment. The range of pH measured on fresh urine from individual rats varied from 5-8. With time, there was a tendency for more samples to have an ncid pH, but this occurred in all groups and could not be related to treatment. Measurements of cell excretion were similar in all groups (Table VI) .
In Exp. 1, concentration/dilution tests performed during the first 12 months showed higher urinary specific gravity and smaller volume from rats in Groups B, D, E and G than in appropriate controls (Table VI) . In the concentration tests, the most statistically significant difference was observed in these 4 groups when specific gravities were compared on the 0-6h sample. In the dilution test, Groups B and D consistently showed highly significant differences of both urinary specific gravity and volume, whereas similar changes in Groups E and G were only statistically significant intermittently. The pattern of changes seen in the dilution test persisted throughout the experiment but, in the concentration test, the differences became less marked with time.
At 50 weeks, a further observation was recorded in Groups B and D, when decreased specific gravities occurred in the 18-24h sample. Similar findings were observed for the remainder of the experiment, but the decreases were not always statistically significant.
In Exp. 2, concentration tests indicated a significant decrease in specific gravity of urine from rats pretreated with MNU (Group I) when 18-24h samples were analysed at 2, 7 and 11 weeks. Concentration tests performed during the rest of the experiment, and dilution tests throughout the experiment, showed no consistent differences between the groups.
Absolute kidney weights were lower in Groups B, D and G than in the relevant controls (Table VIII) Kidney pathology. Glomerulonephrotic changes, consistent with ageing, were seen in all groups (Table VIII) ; the lower incidence of severe glomerulonephrosis seen in Groups B and D again reflected the early. mortality in the MNU and saccharintreated rats. Pyelonephritis occurred in some rats from all groups pretreated with MNU (A-E and I).
In Exp. 1, only MNU-pretreated groups showed hyperplasia of the pelvic epithelium (Fig. 1 ) the incidence being significantly higher after administration of saccharin (Groups B and D) . Microscopic calcium deposits were present in some rats from all groups (A-G) but again with a significantly higher incidence in Groups B and D. Calcification occurred in the collecting ducts, the pelvic epithelium, and the pelvic space, as well as in the area of the cortico-medullary junction. The few macroscopic calculi recorded were associated with MNU treatment.
In Exp. 2, 40% of rats in both Groups I and J and 80% of rats fed saccharin alone (Group H) developed pelvic epithelial hyperplasia. Microscopic calcification was observed in all 3 groups, but again the highest frequency (90%) was in Group H. (Fig. 2) . If more than 20% of the epithelium was hyperplastic, the lesion was termed diffuse. Irregular hyperplasias were basically endophytic in growth pattern, and were characterized by broadfront extensions into the lamina propria, including Von Brunn's nests (Figs 3 and 4) . Papillary hyperplasias were exophytic lesions, consisting of fingerlike projections into the bladder lumen of well differentiated transitional epithelium, surrounding a thin fibro-vascular stroma (Fig. 5 ).
Neoplasms were diagnosed as malignant on the basis of loss of differentiation, cellular atypia, nuclear pleomorphism, number of mitoses and invasion. Inevitably, these judgements were subjective in certain cases, and consequently some exophytic neoplasms were diagnosed as benign papillomas by 2 authors (JH; PG) and as papillary carcinoma in situ (PIS, WHO classification, 1973) by 2 authors (RMH; JC) (Figs 6a,b) .
The bladder lesions observed at interim kills at 1, 6 and 12 months in Exp. 1 are shown in Table IX . One unequivocal neoplasm was seen at, 12 months in Group D.
Terminal bladder pathology for all groups is illustrated in Table X. In Exp. 1, about 3000 of rats in groups pretreated with MNU showed some degree of mild hyperplasia of the bladder epithelium. A smaller number of rats in these groups Pi carcinomas by 2 developed more severe proliferative lesions, the incidence of these lesions being significantly higher in groups given saccharin (B and D). Although 2 authors classified these proliferative changes as irregular or papillary hyperplasias, the other 2 authors diagnosed 15/19 cases as carcinomas, Stages PIS, Pla, or Plb (WHO classification, 1973) . Unequivocal bladder carcinomas were found in all groups pretreated with MNU ( Fig. 7) and a small number of connectivetissue neoplasms occurred in the same groups. Invasion of the bladder musculature was seen in only 6 instances ( Fig. 8 ) and metastases to other organs were never seen. The incidence of neoplasia was not significantly different in any of the groups pretreated with MNU, irrespective of the type of classification used. However, neoplasms were first detected in the saccharin-treated groups (B and D) and the mean latent period was also shorter in these groups (Table XI) . (Hicks et al., 1973a (Hicks et al., , 1975 or a threshold dose of FANFT (Cohen et al., 1979) produced a high incidence of tumours of the urinary bladder.
In the present experiments, it had been intended to use a non-carcinogenic dose of MNU also, but in practice the dose administered, although the same as had been used in earlier studies (Hicks et al., 1975) produced bladder neoplasms in 27% of rats in Exp. 1, and 38% in Exp. 2.
Hyperplastic lesions of the bladder were found in a further third of the rats in each experiment and pathological changes in the kidney, including a small number of neoplasms, were also found after MNU pretreatment. The problem of the varying carcinogenic potency of different batches of MNU has been discussed elsewhere (Hicks et al., 1978) and similar difficulties have been encountered in studies with FANFT (Jacobs et al., 1977; Cohen et al., 1979 OTS, SACCHARIN AND RAT BLADDER CANCER charin-treated rat, implying an earlier development of neoplasia; carcinomas were also seen earlier in other rats from these groups, as a consequence of premature mortality. However, mortality may have been associated with the severe kidney pathology present in these animals and therefore it is not possible to say with certainty that the time to tumour development was shortened.
Administration of both saccharins did increase the number of hyperplasias, including severe hyperplasias, of the bladder epithelium, seen after MNU pretreatment, the finding being significant with OTScontaminated saccharin. Despite differing interpretations by the authors of the classification of certain of these proliferative lesions, the conclusion was unanimous that they occurred more frequently in the saccharin-treated animals than in those receiving MNU alone.
The variable interpretation of certain bladder lesions reflects the absence of a generally agreed system of classification for rat bladder neoplasia, the problem of assessing invasion of the underlying connective tissue, and our incomplete knowledge of the behaviour of such proliferative lesions in the rat bladder. There is no doubt that bladder neoplasia induced by a variety of carcinogens is often preceded by hyperplastic lesions that are papillary or nodular in growth pattern (Tiltman & Friedell, 1971; Kunze et al., 1976) (Shirai et al., 1977) . However, the marked proliferative lesions seen in the present experiments have been regarded by some (Hicks & Chowaniec, 1978) as irreversible conditions, which in many cases show signs of early stromal invasion (Pla or b carcinomas). If this is correct, then preneoplasia develops very early; these lesions were identified in moribund rats killed at 1 and 6 weeks after MNU treatment and in 4-week interim kills. Further experimental work is required in this area before such problems can be resolved.
The failure of saccharin to increase the number of bladder neoplasms after treatment with a carcinogenic dose of MNU is in keeping with the recent results of Mohr et al. (1978) who showed that if the initiating agent was used at a dose that itself produced neoplasia, no promoting effect of saccharin could be demonstrated. These workers observed that daily ingestion of 2% saccharin did not alter the incidence of bladder carcinoma in groups pretreated with a dose of MNU that produced neoplasia in 40%o of rats. Our findings, and those of Mohr et al. (1978) are analagous to the early work on 2-stage carcinogenesis in mouse skin (Berenblum, 1941) . In these experiments, it was found that the tumour incidence after a carcinogenic dose of benzpyrene could not be increased by subsequent application of croton oil, and Berenblum concluded that, in order to demonstrate 2-stage carcinogenesis, the initiating agent must be used at a threshold, or subcarcinogenic dose.
The current experiments were designed to elucidate the role of the saccharin contaminant OTS in the production of bladder cancer. Apart from the consequences arising from a reduced water intake (i.e. reduced body weight, food intake and concentrated urine) addition of OTS to the drinking water did not alter the incidence of toxicological or pathological changes induced by MNU alone; the higher incidence of bladder neoplasia observed in rats pretreated with MNU and given OTS in the diet (Exp. 2) was not significant; a different batch of MNU was used in this experiment, with a greater carcinogenic potential than the batch used in Exp. 1 (Hicks et al., (Kinzer, 1973 (Chowaniec 
